DVN
43
7
CAT
55
-2
CMCSA
59
6
UNP
42
-4
JPM
57
-5
OXY
53
4
AIZ
47
-2
GIS
26
-14
CSX
55
-2
VFC
65
2
JNJ
42
-2
STZ
50
7
RIG
60
5
CSCO
60
3
SLG
62
3
CAH
44
-6
BIIB
37
9
BK
66
-3
OI
28
3
HCA
50
2
DVN
43
7
CAT
55
-2
CMCSA
59
6
UNP
42
-4
JPM
57
-5
OXY
53
4
AIZ
47
-2
GIS
26
-14
CSX
55
-2
VFC
65
2
JNJ
42
-2
STZ
50
7
RIG
60
5
CSCO
60
3
SLG
62
3
CAH
44
-6
BIIB
37
9
BK
66
-3
OI
28
3
HCA
50
2
Financhill
Back

Actinium Pharmaceuticals 10K Form

Sell
35

ATNM
Actinium Pharmaceuticals

Last Price:
1.75
Seasonality Move:
-1.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATNM News And Ratings

See the #1 stock for the next 7 days that we like better than ATNM

ATNM Financial Statistics

Sales & Book Value

Annual Sales: $81K
Cash Flow: $-7.97M
Price / Cash Flow: 0
Annual Sales: $1.43
Price / Book: 1.25

Profitability

EPS (TTM): -1.51000
Net Income (TTM): $-42.62M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Actinium Pharmaceuticals Earnings Forecast

Key Actinium Pharmaceuticals Financial Ratios

  • The Selling, General & Administrative Expenses for ATNM have been equal to 16,458.02% of Gross Profit Margin.
  • The Research & Development expenses have been 47,740.74% of Revenue.
  • The Interest Expense is -0.02% of Operating Income.
  • Per Share Earnings over the last 18 years have been positive in 9 years.

Actinium Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: ATNM
CUSIP: 00507W
Website: actiniumpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATNM Technical Analysis vs Fundamental Analysis

Sell
35
Actinium Pharmaceuticals (ATNM) is a Sell

Is Actinium Pharmaceuticals a Buy or a Sell?